NR supplier Chromadex Joins with Scripps on Breast Cancer Treatment:

Dave in comments pointed to this, which has been discussed in terms of the science but now the business partnership is official:

“Felding’s patented discoveries [at Scripps] include the enhancement of NAD+ metabolism through treatment with NAD+ precursors to potentiate the effects of endocrine therapy in breast cancer, inhibit resistance of breast cancer cells to endocrine therapy, and re-instate sensitivity in breast cancer cells that are unresponsive to endocrine treatments such as Tamoxifen.

“Our research indicates that normalizing tumor cell metabolism could very efficiently enhance cancer therapy,” said Felding. “The planned studies may identify a novel way to enhance treatment responses and improve the quality of life for cancer patients.”

Advertisements
This entry was posted in health, Health Pills and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s